Cargando…
Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination
Vaccination is considered the most important measure to control the COVID-19 pandemic. Extensive follow-up studies with distinct vaccines and populations are able to promote robust and reliable data to better understand the effectiveness of this pharmacologic strategy. In this sense, we present data...
Autores principales: | Guiomar, Raquel, Santos, Ana João, Melo, Aryse Martins, Costa, Inês, Matos, Rita, Rodrigues, Ana Paula, Kislaya, Irina, Silva, Anabela Santos, Roque, Carla, Nunes, Carla, Aguiar, Joaquim, Graça, Fátima, Silva Graça, Antônio, Machado, Ausenda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880181/ https://www.ncbi.nlm.nih.gov/pubmed/35214613 http://dx.doi.org/10.3390/vaccines10020154 |
Ejemplares similares
-
End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in Portugal
por: Kislaya, Irina, et al.
Publicado: (2023) -
Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022
por: Kislaya, Irina, et al.
Publicado: (2023) -
Combining self-reported and objectively measured survey data to improve hypertension prevalence estimates: Portuguese experience
por: Kislaya, Irina, et al.
Publicado: (2021) -
Monitoring COVID-19 and Influenza: The Added Value of a Severe Acute Respiratory Infection Surveillance System in Portugal
por: Torres, Ana Rita, et al.
Publicado: (2023) -
mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021
por: Nunes, Baltazar, et al.
Publicado: (2021)